Medical Oncology, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, C434 Med Inn, SPC 5843, Ann Arbor, MI 48109-5843, USA.
Semin Oncol Nurs. 2012 Aug;28(3):170-9. doi: 10.1016/j.soncn.2012.05.006.
Treatment options for advanced renal cell carcinoma have increased dramatically over the past 6 years as a result of improved understanding of the biology of renal cancer and the development of therapies to target pathways relevant to tumor progression.
Research-based articles.
New therapies to treat advanced renal cell cancer results in a need for evidence-based decision making when discussing treatment choices.
Knowledge of therapeutic strategies, their proposed mechanism of action, potential adverse events, and management strategies provides nurses with a foundation to provide appropriate patient education and effective management of treatment-related side effects, assisting patients to maximize clinical outcomes.
过去 6 年来，由于对肾癌生物学的深入了解以及针对肿瘤进展相关途径的治疗方法的发展，晚期肾细胞癌的治疗选择有了显著的增加。
基于研究的文章。
新的治疗晚期肾细胞癌的方法需要基于证据进行决策，以讨论治疗选择。
了解治疗策略、其提议的作用机制、潜在的不良反应以及管理策略为护士提供了基础，以便为患者提供适当的教育和有效的治疗相关副作用管理，帮助患者最大限度地提高临床疗效。
